Shah K V, Rollison D E
Department of Molecular Microbiology and Immunology, Johns Hopkins University, School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA.
Dis Markers. 2001;17(3):159-61. doi: 10.1155/2001/630740.
In the controversy about the association of simian virus 40 with human cancers, the greatest problem is the ascertainment of SV40 exposure. This difficulty would be resolved if one were to look for all components of SV40 infection. How does SV 40 circulate in the human community? Do cancer patients with SV40-positive tumors have serological correlates of SV 40 infection and of SV40-induced cancer? SV40 association with a cancer should be studied in the context of the known risk factors for that cancer. The tumor cell-virus relationship should be characterized with respect to viral integration and viral localization to the tumor cell. Specimens should be masked and the assays should include panels of specimens to estimate analytic sensitivity and specificity. In view of the rarity of some of the tumors reported to be associated with SV40, a multi-institutional investigation initiated and coordinated by the NIH would be most effective.
在关于猿猴病毒40(SV40)与人类癌症关联的争议中,最大的问题是确定SV40暴露情况。如果能寻找SV40感染的所有组成部分,这个难题就能得到解决。SV40在人类群体中是如何传播的?患有SV40阳性肿瘤的癌症患者是否有SV40感染及SV40诱发癌症的血清学相关指标?SV40与某种癌症的关联应在该癌症已知风险因素的背景下进行研究。肿瘤细胞与病毒的关系应以病毒整合及病毒在肿瘤细胞中的定位来表征。样本应进行盲法处理,检测应包括样本组以评估分析的敏感性和特异性。鉴于一些据报道与SV40相关的肿瘤较为罕见,由美国国立卫生研究院发起并协调的多机构调查将最为有效。